Pliant Therapeutics Inc (PLRX) Unusual Options Activity Today

Checking PLRX unusual options activity helps you spot when traders are making outsized bets on Pliant Therapeutics Inc before the broader market catches on. Pliant Therapeutics Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor PLRX unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching PLRX unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking PLRX unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and PLRX unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a trials. The company also develops PLN-1474, a small-molecule selective inhibitor of avß1, which completed Phase 1 clinical trial for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis. In addition, it is developing two additional preclinical integrin-based programs, which include an oncology program, as well as a program for an allosteric agonistic monoclonal antibody against an undisclosed integrin receptor for treatment of muscular dystrophies, including duchenne muscular dystrophy.

Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.

Catalysts rarely arrive without a footprint, and PLRX unusual options activity is often where that footprint shows up first. Our scanner tracks Pliant Therapeutics Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at PLRX unusual options volume on the call side or chasing put sweeps, Pliant Therapeutics Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.